A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods PW Serruys, JA Ormiston, Y Onuma, E Regar, N Gonzalo, ... The Lancet 373 (9667), 897-910, 2009 | 964 | 2009 |
Instantaneous wave-free ratio versus fractional flow reserve to guide PCI M Götberg, EH Christiansen, IJ Gudmundsdottir, L Sandhall, ... New England Journal of Medicine 376 (19), 1813-1823, 2017 | 860 | 2017 |
A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial JA Ormiston, PW Serruys, E Regar, D Dudek, L Thuesen, MWI Webster, ... The Lancet 371 (9616), 899-907, 2008 | 856 | 2008 |
Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients … V Farooq, D Van Klaveren, EW Steyerberg, E Meliga, Y Vergouwe, ... The Lancet 381 (9867), 639-650, 2013 | 842 | 2013 |
A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II … PW Serruys, B Chevalier, D Dudek, A Cequier, D Carrié, A Iniguez, ... The Lancet 385 (9962), 43-54, 2015 | 647 | 2015 |
Effects of the Direct Lipoprotein-Associated Phospholipase A2 Inhibitor Darapladib on Human Coronary Atherosclerotic Plaque PW Serruys, HM García-García, P Buszman, P Erne, S Verheye, ... Circulation 118 (11), 1172-1182, 2008 | 644* | 2008 |
Standardized end point definitions for coronary intervention trials: the academic research consortium-2 consensus document HM Garcia-Garcia, EP McFadden, A Farb, R Mehran, GW Stone, ... Circulation 137 (24), 2635-2650, 2018 | 539 | 2018 |
In vivo intravascular ultrasound-derived thin-cap fibroatheroma detection using ultrasound radiofrequency data analysis GA Rodriguez-Granillo, HM García-García, EP Mc Fadden, M Valgimigli, ... Journal of the American College of Cardiology 46 (11), 2038-2042, 2005 | 486 | 2005 |
Evaluation of the second generation of a bioresorbable everolimus-eluting vascular scaffold for the treatment of de novo coronary artery stenosis: 12-month clinical and imaging … PW Serruys, Y Onuma, D Dudek, PC Smits, J Koolen, B Chevalier, ... Journal of the American College of Cardiology 58 (15), 1578-1588, 2011 | 461 | 2011 |
Evaluation of the second generation of a bioresorbable everolimus drug-eluting vascular scaffold for treatment of de novo coronary artery stenosis: six-month clinical and … PW Serruys, Y Onuma, JA Ormiston, B de Bruyne, E Regar, D Dudek, ... Circulation 122 (22), 2301-2312, 2010 | 416 | 2010 |
In vivo detection of high-risk coronary plaques by radiofrequency intravascular ultrasound and cardiovascular outcome: results of the ATHEROREMO-IVUS study JM Cheng, HM Garcia-Garcia, SPM de Boer, I Kardys, JH Heo, ... European heart journal 35 (10), 639-647, 2014 | 368 | 2014 |
From metallic cages to transient bioresorbable scaffolds: change in paradigm of coronary revascularization in the upcoming decade? PW Serruys, HM Garcia-Garcia, Y Onuma European heart journal 33 (1), 16-25, 2012 | 367 | 2012 |
Optical coherence tomography patterns of stent restenosis N Gonzalo, PW Serruys, T Okamura, HM van Beusekom, ... American heart journal 158 (2), 284-293, 2009 | 360 | 2009 |
Impact of nationwide centralization of pancreaticoduodenectomy on hospital mortality Dutch Pancreatic Cancer Group de Wilde RF Besselink MGH van der Tweel I de ... Journal of British Surgery 99 (3), 404-410, 2012 | 351 | 2012 |
Intracoronary optical coherence tomography and histology at 1 month and 2, 3, and 4 years after implantation of everolimus-eluting bioresorbable vascular scaffolds in a porcine … Y Onuma, PW Serruys, LEL Perkins, T Okamura, N Gonzalo, ... Circulation 122 (22), 2288-2300, 2010 | 349 | 2010 |
Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a … M Haude, H Ince, A Abizaid, R Toelg, PA Lemos, C Von Birgelen, ... The Lancet 387 (10013), 31-39, 2016 | 343 | 2016 |
A new tool for the risk stratification of patients with complex coronary artery disease: the Clinical SYNTAX Score S Garg, G Sarno, HM Garcia-Garcia, C Girasis, J Wykrzykowska, ... Circulation: Cardiovascular Interventions 3 (4), 317-326, 2010 | 336 | 2010 |
Stabilisation of atherosclerotic plaques S Ylä-Herttuala, JF Bentzon, M Daemen, E Falk, HM Garcia-Garcia, ... Thrombosis and haemostasis 106 (07), 1-19, 2011 | 325* | 2011 |
The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous … V Farooq, PW Serruys, HM Garcia-Garcia, Y Zhang, CV Bourantas, ... Journal of the American College of Cardiology 61 (3), 282-294, 2013 | 318 | 2013 |
Tissue characterisation using intravascular radiofrequency data analysis: recommendations for acquisition, analysis, interpretation and reporting. HM García-García, GS Mintz, A Lerman, DG Vince, MP Margolis, ... EuroIntervention: journal of EuroPCR in collaboration with the Working Group …, 2009 | 312 | 2009 |